Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.7 ILa | -3.57% | -3.57% | +3.85% |
May. 12 | Transcript : Can-Fite BioPharma Ltd. - Special Call | |
May. 09 | Can-Fite BioPharma Ltd. Announces FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study | CI |
Sales 2024 * | 900K 334M | Sales 2025 * | 900K 334M | Capitalization | 10.91M 4.04B |
---|---|---|---|---|---|
Net income 2024 * | -7M -2.6B | Net income 2025 * | -8M -2.97B | EV / Sales 2024 * | 12.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 12.1 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.97% |
Latest transcript on Can-Fite BioPharma Ltd.
1 day | -3.57% | ||
1 week | -3.57% | ||
Current month | +3.85% | ||
1 month | +3.85% | ||
3 months | +3.85% | ||
6 months | -3.57% | ||
Current year | +3.85% |
Managers | Title | Age | Since |
---|---|---|---|
Motti Farbstein
CEO | Chief Executive Officer | 59 | 03-07-31 |
Pnina Fishman
FOU | Founder | 74 | 94-09-10 |
Ilan Cohn
FOU | Founder | 68 | 94-09-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Abraham Sartani
BRD | Director/Board Member | 76 | 00-12-31 |
Ilan Cohn
FOU | Founder | 68 | 94-09-10 |
Pnina Fishman
FOU | Founder | 74 | 94-09-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-30 | 2.7 | -3.57% | 7,657,102 |
24-05-29 | 2.8 | -.--% | 10,226,920 |
24-05-28 | 2.8 | -.--% | 1,751,177 |
24-05-27 | 2.8 | -.--% | 1,206,422 |
24-05-26 | 2.8 | -.--% | 1,703,320 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 30, 2024 at 10:24 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.85% | 10.91M | |
-2.29% | 89.38B | |
-3.95% | 37.92B | |
-13.07% | 32.04B | |
+63.05% | 26.03B | |
-22.14% | 14.14B | |
-7.96% | 12.88B | |
-9.33% | 11.77B | |
-46.33% | 10.85B | |
+5.77% | 8.92B |
- Stock Market
- Equities
- CANF Stock